BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 26240025)

  • 1. Serum lactate dehydrogenase levels at presentation in stage IV non-small cell lung cancer: predictive value of metastases and relation to survival outcomes.
    Lee DS; Park KR; Kim SJ; Chung MJ; Lee YH; Chang JH; Kang JH; Hong SH; Kim MS; Kim YS
    Tumour Biol; 2016 Jan; 37(1):619-25. PubMed ID: 26240025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A laboratory prognostic index model for patients with advanced non-small cell lung cancer.
    Ulas A; Turkoz FP; Silay K; Tokluoglu S; Avci N; Oksuzoglu B; Alkis N
    PLoS One; 2014; 9(12):e114471. PubMed ID: 25474743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical features and prognostic factors in patients with bone metastases from non-small cell lung cancer.
    Wu XT; Zhou JW; Pan LC; Ge T
    J Int Med Res; 2020 May; 48(5):300060520925644. PubMed ID: 32425092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated lactic acid is a negative prognostic factor in metastatic lung cancer.
    Vlachostergios PJ; Oikonomou KG; Gibilaro E; Apergis G
    Cancer Biomark; 2015; 15(6):725-34. PubMed ID: 26406401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of diabetes mellitus in locally advanced non-small cell lung cancer.
    Imai H; Kaira K; Mori K; Ono A; Akamatsu H; Matsumoto S; Taira T; Kenmotsu H; Harada H; Naito T; Murakami H; Endo M; Nakajima T; Yamada M; Takahashi T
    BMC Cancer; 2015 Dec; 15():989. PubMed ID: 26690494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prognostic factors in unresectable lung cancer].
    Urata A
    Gan To Kagaku Ryoho; 1988 Jul; 15(7):2035-42. PubMed ID: 2840034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of lactate dehydrogenase B according to histologic type of non-small-cell lung cancer and its association with serum lactate dehydrogenase.
    Koh YW; Lee SJ; Park SY
    Pathol Res Pract; 2017 Sep; 213(9):1134-1138. PubMed ID: 28756978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Value of pretreatment serum lactate dehydrogenase as a prognostic and predictive factor for small-cell lung cancer patients treated with first-line platinum-containing chemotherapy.
    He M; Chi X; Shi X; Sun Y; Yang X; Wang L; Wang B; Li H
    Thorac Cancer; 2021 Dec; 12(23):3101-3109. PubMed ID: 34725930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic and prognostic value of serum thioredoxin and DJ-1 in non-small cell lung carcinoma patients.
    Fan J; Yu H; Lv Y; Yin L
    Tumour Biol; 2016 Feb; 37(2):1949-58. PubMed ID: 26334622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overall survival of cancer patients with serum lactate dehydrogenase greater than 1000 IU/L.
    Liu R; Cao J; Gao X; Zhang J; Wang L; Wang B; Guo L; Hu X; Wang Z
    Tumour Biol; 2016 Oct; 37(10):14083-14088. PubMed ID: 27511116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Significance of Preoperative Serum Lactate Dehydrogenase in Upper Urinary Tract Urothelial Carcinoma.
    Zhang XK; Zhang ZL; Lu X; Yang P; Cai MY; Hu WM; Yun JP; Zhou FJ; Qian CN; Cao Y
    Clin Genitourin Cancer; 2016 Aug; 14(4):341-345.e3. PubMed ID: 26868330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of lactate deshydrogenase levels on non-small cell lung cancer prognosis: a meta-analysis.
    Gong T; Liu J; Jiang J; Zhai YF; Wu CM; Ma C; Wen BL; Yan XY; Zhang X; Wang DM; Lu Q; Qu YL
    Cell Mol Biol (Noisy-le-grand); 2019 Jan; 65(1):89-93. PubMed ID: 30782303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic and Prognostic Value of Serum Angiopoietin-Like Protein 2 in Patients with Non-Small Cell Lung Cancer.
    Chen Y; Jiang H; Zhu L; Wang P; Liu S; Xiao X; Yu H; Dong W
    Clin Lab; 2017 Jan; 63(1):59-65. PubMed ID: 28164488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Change in Serum Lactate Dehydrogenase Is Associated with Outcome of Patients with Advanced-stage NSCLC Treated with Erlotinib.
    Fiala O; Pesek M; Finek J; Topolcan O; Racek J; Svaton M; Kucera R; Minarik M; Benesova L; Bortlicek Z; Chloupkova R; Poprach A; Buchler T
    Anticancer Res; 2016 May; 36(5):2459-65. PubMed ID: 27127158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of serum LDH in small cell lung cancer: A systematic review with meta-analysis.
    Zhang X; Guo M; Fan J; Lv Z; Huang Q; Han J; Wu F; Hu G; Xu J; Jin Y
    Cancer Biomark; 2016; 16(3):415-23. PubMed ID: 27062698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of increased mean platelet volume (MPV) and decreased MPV/platelet count ratio as poor prognostic factors in lung cancer.
    Omar M; Tanriverdi O; Cokmert S; Oktay E; Yersal O; Pilancı KN; Menekse S; Kocar M; Sen CA; Ordu C; Goksel G; Meydan N; Barutca S;
    Clin Respir J; 2018 Mar; 12(3):922-929. PubMed ID: 28026133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum neuron-specific enolase and lactate dehydrogenase as predictors of response to chemotherapy and survival in non-small cell lung cancer.
    van Zandwijk N; Jassem E; Bonfrer JM; Mooi WJ; van Tinteren H
    Semin Oncol; 1992 Feb; 19(1 Suppl 2):37-43. PubMed ID: 1329221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating U2 small nuclear RNA fragments as a diagnostic and prognostic biomarker in lung cancer patients.
    Köhler J; Schuler M; Gauler TC; Nöpel-Dünnebacke S; Ahrens M; Hoffmann AC; Kasper S; Nensa F; Gomez B; Hahnemann M; Breitenbuecher F; Cheufou D; Özkan F; Darwiche K; Hoiczyk M; Reis H; Welter S; Eberhardt WE; Eisenacher M; Teschler H; Stamatis G; Schmiegel W; Hahn SA; Baraniskin A
    J Cancer Res Clin Oncol; 2016 Apr; 142(4):795-805. PubMed ID: 26687686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of the baseline serum uric acid level in non-small cell lung cancer patients treated with first-line chemotherapy: a study of the Turkish Descriptive Oncological Researches Group.
    Tanriverdi O; Cokmert S; Oktay E; Pilanci KN; Menekse S; Kocar M; Sen CA; Avci N; Akman T; Ordu C; Goksel G; Meydan N
    Med Oncol; 2014 Oct; 31(10):217. PubMed ID: 25216865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic significance of pretreatment serum lactate dehydrogenase in patients with small-cell lung cancer.
    Sagman U; Feld R; Evans WK; Warr D; Shepherd FA; Payne D; Pringle J; Yeoh J; DeBoer G; Malkin A
    J Clin Oncol; 1991 Jun; 9(6):954-61. PubMed ID: 1851821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.